CPT code 67961 denotes surgical excision of diseased or damaged eyelid tissue with repair that may include a skin graft or adjacent tissue transfer to close a defect involving up to one fourth of the eyelid margin. This procedure is clinically important for treating eyelid malignancies, trauma, or chronic tissue loss where both functional integrity and cosmesis of the lid margin are priorities. Nationally, accurate coding for eyelid excision and limited reconstruction affects outcomes tracking, coverage determinations, and reimbursement consistency across payers.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines clinical context, facility and professional service considerations, and payer-specific coverage nuances where available. Readers will find benchmarks and policy-relevant observations about billing practice for limited eyelid margin reconstruction, typical sites of service, and common documentation elements necessary to support medical necessity. Data not available in the input for certain fields is noted where applicable.

This summary equips clinicians, coding professionals, and policy analysts with a concise reference to CPT code 67961, its clinical indication, and the payer landscape to inform coding, claims submission, and utilization review decisions at a national level.